Advanced Biomedical Technologies Inc (ABMT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
(Values in U.S. thousands)
| 10-2022 | 10-2021 | 10-2020 | 10-2019 | 10-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -516 | -729 | -672 | -949 | -953 |
| Depreciation Amortization | 19 | 41 | 60 | 21 | 16 |
| Other Working Capital | -267 | -201 | 1,186 | 157 | 38 |
| Other Operating Activity | 30 | 45 | 72 | 28 | 67 |
| Operating Cash Flow | $-734 | $-844 | $647 | $-743 | $-832 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -52 | -31 | -19 | -64 |
| Investing Cash Flow | $N/A | $-52 | $-31 | $-19 | $-64 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 703 | 724 | -428 | 760 | 896 |
| Financing Cash Flow | $703 | $724 | $-428 | $760 | $896 |
| Exchange Rate Effect | -2 | 7 | 8 | 0 | 0 |
| Beginning Cash Position | 37 | 202 | 6 | 7 | 8 |
| End Cash Position | 5 | 37 | 202 | 6 | 7 |
| Net Cash Flow | $-32 | $-165 | $196 | $-1 | $-1 |
| Free Cash Flow | |||||
| Operating Cash Flow | -734 | -844 | 647 | -743 | -832 |
| Capital Expenditure | N/A | -52 | -31 | -19 | -64 |
| Free Cash Flow | -734 | -896 | 616 | -761 | -897 |